Drug-Induced Autoimmune Inflammatory Myositis in a Patient with Psoriatic Arthritis Receiving Biologic Therapy: A Case Report
Key Points: 1. Although uncommon, autoimmune inflammatory myositis is a clinically significant adverse event that has been reported in association with biologic and targeted immunomodulatory therapies used for inflammatory rheumatic diseases, making early recognition essential.2.This case report describes a patient with psoriatic arthritis who developed autoimmune inflammatory myositis after prolonged sequential exposure to multiple biologic…